Target intelligence / Profile preview

Virus-infected cells presenting adenovirus antigens

Molecular classification
Cell, MHC Class I complex, Antigen-presenting cell
01

Overview

Virus-infected cells presenting adenovirus antigens are host cells that have been infected by adenoviruses and subsequently display viral antigens on their surface, primarily via the major histocompatibility complex (MHC) class I pathway. These presented antigens are recognized by the immune system, particularly cytotoxic T lymphocytes (CTLs), which target and eliminate infected cells to control infection. Adenoviruses have evolved immune evasion mechanisms, such as the E19 protein, which inhibits MHC class I presentation. These cells serve as key targets for vaccine development and cancer therapy using oncolytic or gene therapy vectors.

Other names
Adenovirus-infected cells presenting viral antigensAdenovirus-infected cells displaying MHC-I-peptide complexes
02

Mechanism of action

N/A

03

Biological functions

Antigen presentationImmune response activationT cell activationCytokine production
04

Disease associations

InfectionCancer (in oncolytic virus therapy)Vaccine target
05

Safety considerations

Off-target effects of immune responseCytokine stormTumor lysis syndrome (in oncolytic therapy)Anti-vector immunity

Beyond the preview

Go deeper on Virus-infected cells presenting adenovirus antigens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Virus-infected cells presenting adenovirus antigens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call